Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital.


Journal

International journal of hygiene and environmental health
ISSN: 1618-131X
Titre abrégé: Int J Hyg Environ Health
Pays: Germany
ID NLM: 100898843

Informations de publication

Date de publication:
09 2020
Historique:
received: 08 06 2020
revised: 20 07 2020
accepted: 22 07 2020
pubmed: 18 8 2020
medline: 16 11 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Environmental contamination by patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through respiratory droplets suggests that surfaces and equipment could be a medium of transmission. We aimed to assess the surface and equipment contamination by SARS-COV-2 of an emergency department (ED) during the coronavirus infectious disease-2019 (COVID-19) outbreak. We performed multiple samples from different sites in ED patients care and non-patient care areas with sterile premoistened swabs and used real-time reverse transcriptase polymerase chain reaction (RT-PCR) to detect the presence of SARS-CoV-2 ribonucleic acid (RNA). We also sampled the personal protective equipment (PPE) from health care workers (HCWs). Among the 192 total samples, 10 (5.2%) were positive. In patient care areas, 5/46 (10.9%) of the surfaces directly in contact with COVID-19 patients revealed the presence of SARS-CoV-2 RNA, and 4/56 (7.1%) of the surfaces that were not directly in contact with COVID-19 patients were positive. SARS-CoV-2 RNA was present only in the patients' examination and monitoring rooms. Before decontamination SARS-CoV-2 RNA was present on the saturation clip, the scuff for blood pressure measurement, the stretcher, the plastic screens between patients and the floor. After decontamination, SARS-CoV-2 RNA remained on the scuff, the stretcher and the trolleys. All samples from non-patient care areas or staff working rooms were negative. Only one sample from the PPE of the HCWs was positive. Our findings suggest that surfaces and equipment contamination by SARS-CoV-2 RNA in an ED during the COVID-19 outbreak is low and concerns exclusively patients' examination and monitoring rooms, preserving non-patient care areas.

Identifiants

pubmed: 32799101
pii: S1438-4639(20)30546-0
doi: 10.1016/j.ijheh.2020.113600
pmc: PMC7413114
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113600

Investigateurs

Y Achili (Y)
L Ades (L)
L Aguinaga (L)
G Archer (G)
A Benattia (A)
B Bercot (B)
A Bergeron (A)
R Bertinchamp (R)
L Bondeelle (L)
J D Bouaziz (JD)
D Bouda (D)
D Boutboul (D)
I Brindel Berthon (I)
E Brugnet (E)
S Caillat Zucman (S)
S Cassonnet (S)
K Celli Lebras (K)
J Chabert (J)
M L Chaix (ML)
S Chevret (S)
M Clément (M)
C Davoine (C)
N De Castro (N)
E De Kerviler (E)
C De Margerie-Mellon (C)
F Depret (F)
B Denis (B)
L Djaghout (L)
C Dupin (C)
D Farge-Blancel (D)
C Fauvaux (C)
H Fenaux (H)
E Feredj (E)
D Feyeux (D)
V Fremeaux-Bacchi (V)
L Galicier (L)
J Garestier (J)
S Harel (S)
A L Jegu (AL)
E Kozakiewicz (E)
A Lebel M Baye (A)
P Le Guen (P)
E Lengline (E)
G Liegeon (G)
G Lorillon (G)
I Madelaine Chambrin (I)
G Martin de Frémont (G)
S Maylin (S)
C Mehlman (C)
M Meunier (M)
J M Molina (JM)
F Morin (F)
E Oksenhendler (E)
R Peffault de la Tour (R)
B Plaud (B)
M Rouveau (M)
J Saussereau (J)
N Schnepf (N)
J Soret (J)
A Tazi (A)
M T Tremorin (MT)

Informations de copyright

Copyright © 2020 Elsevier GmbH. All rights reserved.

Auteurs

Olivier Peyrony (O)

Emergency Department, Saint-Louis Hospital, AP-HP, Paris, France. Electronic address: olivier.peyrony@aphp.fr.

Sami Ellouze (S)

Emergency Department, Saint-Louis Hospital, AP-HP, Paris, France. Electronic address: sami.ellouze@aphp.fr.

Jean-Paul Fontaine (JP)

Emergency Department, Saint-Louis Hospital, AP-HP, Paris, France. Electronic address: jean-paul.fontaine@aphp.fr.

Micheline Thegat-Le Cam (M)

Infection Control Team, Saint-Louis Hospital, AP-HP, Paris, France. Electronic address: micheline.thegat@aphp.fr.

Maud Salmona (M)

Université de Paris, Virology Department, Saint-Louis Hospital, AP-HP, INSERM U976, Paris, France. Electronic address: maud.salmona@aphp.fr.

Linda Feghoul (L)

Université de Paris, Virology Department, Saint-Louis Hospital, AP-HP, INSERM U944, Paris, France. Electronic address: linda.feghoul@aphp.fr.

Nadia Mahjoub (N)

Virology Department, Saint-Louis Hospital, AP-HP, Paris, France. Electronic address: nadia.mahjoub@aphp.fr.

Séverine Mercier-Delarue (S)

Virology Department, Saint-Louis Hospital, AP-HP, Paris, France. Electronic address: severine.mercier-delarue@aphp.fr.

Audrey Gabassi (A)

Virology Department, Saint-Louis Hospital, AP-HP, Paris, France. Electronic address: audrey.gabassi@aphp.fr.

Constance Delaugerre (C)

Université de Paris, Virology Department, Saint-Louis Hospital, AP-HP, INSERM U944, Paris, France. Electronic address: constance.delaugerre@aphp.fr.

Jérôme Le Goff (J)

Université de Paris, Virology Department, Saint-Louis Hospital, AP-HP, INSERM U976, Paris, France. Electronic address: jerome.le-goff@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH